Yea, there has been some pumpin rhetoric for sure. Usually identified by promotional style comments lacking any substance. Anyways, pumping talk in my opinion doesn't help.
But, lets see what happens between now and end of year. The company will or won't survive its toxic financing and turn things around with US RapiMed distribution, strong revenues in the retail pharmacy distribution venture, and some exciting developments from China.
News 
Market Data 
Discover 
